Dec 15, 2013 by DAVE MIHALOVIC
Citing
low demand, high costs - and questioning the benefits, Utah’s Public
Department of Health does not stock or recommend Gardasil HPV vaccine.
The decision to exclude the vaccine from its public health clinics was
made by the agency’s director, contrary to the area's Board of Health.
“The
backlash and sentiment against it was strong enough that there’s no
reason to go there,” physician David Blodgett explained. “No one wants
it and it’s too expensive when we’re not funded to provide it.”
The
vaccine isn’t mandated in Utah. But the Utah Department of Health has
been recommending it for preteen girls since 2006, and for boys since
2011.
At 42 percent, Utah ranks lowest in the nation for completion of the three-injection series among girls who start it.
Unproven Science and Increasing Reports of Side Effects
Official
reasons for the slow uptake are varied, but informed parents who have
increasingly become skeptical of vaccination, especially the HPV vaccine
are likely making the difference.
Just a few months ago,
hundreds of adverse reactions from the cervical cancer vaccine in Japan caused vaccine injuries and disability in many teenagers courtesy of Cervarix and Gardasil HPV injections. In July, 2013,
the Japanese health ministry issued a nationwide notice
that cervical cancer vaccinations should no longer be recommended in
Japan. Japanese teens who received the vaccines are now in wheelchairs
with damage to their brains and spinal cord.
The HPV vaccine is possibly the biggest vaccine hoax in the last century.
HPV vaccines are nothing more than a worldwide exercise in profiteering
at the expense of children's health. Due to the overwhelming amount of
side effects associated with the vaccine, health agencies are now encouraging health professionals not to report adverse reactions, a clear indication that something is very wrong.
Earlier this month, Mr. Jean-Christophe Coubris, defence lawyer for Marie-Oceane, a
HPV vaccine injured teen, has filed charges with the French public prosecutor in Bobigny, in the outskirts of Paris, against both
Laboratoire Sanofi Pasteur MSD and the French authority
Agence Nationale du Medicament (ANSM),
the French National Medicines Agency, for breach of their manifest duty
to ensure safety and for disregard of the precautionary and prevention
principles.
“To be dissuaded by cost issues, or to not stock the
vaccine due to low public demand, is disingenuous, especially for
someone with responsibilities to protect the public,” said said William
Cosgrove, a pediatrician in Murray and a member of the Utah Scientific
Immunization Advisory Committee. “I believe the real medical issues here
are clouded by a moralistic belief system that precludes any frank
discussion about sexuality in adolescents.”
Blodgett cites other
problems with Gardasil, namely that it was fast-tracked through the Food
and Drug Administration (FDA) and a belief that its benefits were
oversold by drug maker Merck.
Thanks to the wealth of information
available on the HPV vaccine, the proportion of insured girls and young
women completing the human papillomavirus (HPV) vaccine among those who
initiated the series
has dropped significantly -- as much as 63 percent -- since the vaccine was approved in 2006, according to new research from the University of Texas Medical Branch (UTMB) in Galveston.
The
study, published in Cancer, reveals the steepest decline in vaccine
completion among girls and young women aged nine to 18 -- the age group
according to medical officials that should receive the vaccine in three
doses over six months -- a message that has been drilled into parents
for just over five years.
“The science wasn’t good... We had physicians in our community arguing that we not make it available,” said Blodgett.
Just two years ago, a publication in the
Annals of Medicine exposed the
fraudulent nature of Human papillomavirus (HPV)
vaccines. Key messages the researchers report include a lack of
evidence for any HPV vaccines in preventing cervical cancer and lack of
evaluation of health risks. The researchers stated that physicians
should adopt a more rigorous evidence-based medicine approach, in order
to provide a balanced and objective evaluation of vaccine risks and
benefits to their patients.
The Public Isn't Buying Medical Hype
It’s
not the only risk and the vaccine is claimed to cut the risk by only 17
percent. Cancers caused by HPV are extremely rare and vaccination comes
with no guarantee for long-term protection and high risk of side
effects.
Weighed against the vaccine’s risks, “the public isn’t
buying it,” said Blodgett. “It’s eroding public trust in immunization
programs.”
“It’s a complicated vaccine that requires discussion
about [sexual health] and a physical exam and follow-up visits with a
doctor,” said the agency’s director, Joseph Shaffer. “My feeling is
that’s better held in the physician’s office than here at the health
department.”
Fear that Gardasil is dangerous hasn’t been eased by
the FDA’s assurances. The agency approved and monitors the drug and says
its safety profile matches those of other vaccines, but the evidence
that continues to coming forward from the U.S. and around the world are
proving different.
Earlier this month, national talk show host Katie Couric
featured a woman on daytime TV who said the HPV vaccine killed her daughter. The show was roundly criticized by other media, including Slate and Forbes magazine.
Sources: sltrib.com
Dave Mihalovic is a Naturopathic Doctor who specializes in vaccine research, cancer prevention and a natural approach to treatment.
Reference Sources
